![Charles Theuer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 596 498 $ au 30/09/2026
Charles P.
Theuer is currently Chief Medical Officer at Halozyme Therapeutics, Inc. since 2024.
He is an Independent Director at Oncternal Therapeutics, Inc. since 2018 and at 4D Molecular Therapeutics, Inc. since 2015.
Formerly, Dr. Theuer was President, Chief Executive Officer & Director at TRACON Pharmaceuticals, Inc. from 2021 to 2024.
He was Director-Clinical Oncology at Pfizer Inc. from 2003 to 2004.
He served as Chief Medical Officer & VP-Clinical Development at TargeGen, Inc. from 2004 to 2006.
He was Assistant Professor-Surgical Oncology at the University of California, Irvine.
He was Principal at the National Cancer Institute from 1991 to 1993.
Dr. Theuer completed undergraduate studies at Massachusetts Institute of Technology in 1985.
He earned a doctorate from The University of California, San Francisco in 1989 and another doctorate from the University of California, Irvine in 2002.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/06/2026 | 41 684 ( 0,08 % ) | 596 498 $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/12/2015 |
| ONCTERNAL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/05/2018 |
| HALOZYME THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| TRACON PHARMACEUTICALS, INC. | Directeur Général | 31/07/2024 |
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures vascular biopharmaceutical products | Directeur Technique/Scientifique/R&D | 01/01/2006 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2004 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | 01/01/1993 |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures vascular biopharmaceutical products | Health Technology |
TRACON Pharmaceuticals, Inc.
 TRACON Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel targeted therapeutics for cancer treatment | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Oncternal Therapeutics, Inc.
 Oncternal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that manufactures pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
